VALBIOTIS SA: Valbiotis presents the full results of the Pha

VALBIOTIS SA VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes 11-Sep-2023 / 17:40 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The i...

Related Keywords

United States , France , French , American , Agence Monet , Carole Rocher , Seitosei Actifin , Marc Delaunay , Rue Paul Vatine , Health Science , Public Affairs , American Diabetes Association , News Service , International Diabetes Federation , Valbiotis Executive Committee , French Regulatory News , Valbiotis Executive , International Diabetes , Valbiotis Universal Registration Document , French Financial Markets Regulator , True Paul , Sa , Valbiotis , A , Hase , I Iii , Reverse It , Otum 63 , Et Cest , Dissemination , Egulatory , News , , Qs , Group ,